content

PHARMASEAL, a provider of clinical trial management and governance solutions, announced today that it has secured its first Medical Device customer – an award-winning...

Raremark®, the global healthtech company specializing in rare disease, has today announced the appointment of Dale Jessop as Chief Technical Officer. Jessop brings a wealth...

AstraZeneca and the Hong Kong Science and Technology Parks Corporation (HKSTP) have launched a co-incubation programme to support biomedical startups in their mission to...

AbbVie and Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome editing biotechnology company, announced that they have entered into a collaboration and license agreement...

Global contract development and manufacturing organisation (CDMO), Recipharm, has successfully extended its manufacturing license to include immunology products, allowing them to cater for customers’...

According to Marcelo Cruz, Director Business Development and Marketing at Tjoapack One of the key trends transforming the pharmaceutical industry in recent years has been the...

The U.S. FDA granted EUA for investigational bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together, Eli Lilly and Company announced. This therapy...